Working from our state-of-the art facilities, CAT’s experienced fish and shrimp health team provide timely, reliable results in the determination of efficacy of existing or novel products of existing or novel aqua health products. As a certifed Aquatic Animal Pathogen Containment Level 3 (AQC3) biocontainment facility, we have the opportunity to conduct in vivo and in vitro studies with imported as well as domestic aquatic animal pathogens. Our regulatory-compliant studies are carried out to the established standards of Good Clinical Practices (GCP) and Good Laboratory Practices (GLP) as required for client-specific applications.


  • Trials to GLP/GCP specifications
  • Established and custom trial design
  • In vitro and in vivo safety, efficacy and trait association studies
  • Biosafety Level 3
  • Freshwater & marine species
  • Cold & warm water species
Biosafety Level

AQC3/BSL-2 Aquariums

  • Individual Research Modules
  • In-House Diagnostics
  • In Vivo Studies
  • Evaluation of Fish Health Products and Functional Feeds
  • Family Studies for Brood Stock Selection
Biosafety Level

AQC2/BSL-2 Dry Lab

  • In Vitro Direct and Indirect Pathogen Action
  • Biochemistry
  • Pathogen Characterization
  • Biomarker Identification
  • Environmental Monitoring

Source Animals

Commercial strains of Atlantic salmon of varying sizes are available from our in-house stock, however, salmon may be imported from other sources as well. Other species (trout, shrimp, tilapia, etc.) are sourced from local and international suppliers in compliance with Canadian regulations. CAT facilities include a quarantine unit for the purpose of isolating animals. Source animals are tested for common, disease-causing organisms before they arrive or while they are in quarantine at our facilities.

Disease Challenge Models





Contact our Health team for more information